Table 1.
Patient characteristics by organ-specific complications
|
Patients having complications |
Organ-specific complications |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total number of patients | Any complication | Systemic | Renal | Gastrointestinal (including liver) | Cardiovascular | Neurological | Respiratory* | ||
| Total number of patients | 73 197 | 36 367 (49·7%) | 11 895 (16·3%) | 17 752 (24·3%) | 7901 (10·8%) | 8973 (12·3%) | 3115 (4·3%) | 13 486 (18·4%) | |
| Age on admission, years | |||||||||
| 19–29 | 1500 (2·0%) | 411 (1·1%) | 147 (1·2%) | 126 (0·7%) | 139 (1·8%) | 47 (0·5%) | 38 (1·2%) | 145 (1·1%) | |
| 30–39 | 2753 (3·8%) | 1015 (2·8%) | 376 (3·2%) | 353 (2·0%) | 365 (4·6%) | 134 (1·5%) | 91 (2·9%) | 457 (3·4%) | |
| 40–49 | 4996 (6·8%) | 2170 (6·0%) | 731 (6·1%) | 874 (4·9%) | 740 (9·4%) | 370 (4·1%) | 162 (5·2%) | 1169 (8·7%) | |
| 50–59 | 9101 (12·4%) | 4418 (12·1%) | 1504 (12·6%) | 2078 (11·7%) | 1468 (18·6%) | 847 (9·4%) | 352 (11·3%) | 2263 (16·8%) | |
| 60–69 | 11 139 (15·2%) | 5954 (16·4%) | 2008 (16·9%) | 3055 (17·2%) | 1578 (20·0%) | 1389 (15·5%) | 500 (16·1%) | 2767 (20·5%) | |
| 70–79 | 16 563 (22·6%) | 8549 (23·5%) | 2727 (22·9%) | 4318 (24·3%) | 1644 (20·8%) | 2220 (24·7%) | 725 (23·3%) | 2978 (22·1%) | |
| 80–89 | 19 900 (27·2%) | 10 207 (28·1%) | 3241 (27·2%) | 5161 (29·1%) | 1478 (18·7%) | 2888 (32·2%) | 941 (30·2%) | 2761 (20·5%) | |
| ≥90 | 7245 (9·9%) | 3643 (10·0%) | 1161 (9·8%) | 1787 (10·1%) | 489 (6·2%) | 1078 (12·0%) | 306 (9·8%) | 946 (7·0%) | |
| Sex at birth | |||||||||
| Female | 31 977 (43·7%) | 14 521 (39·9%) | 4872 (41·0%) | 6612 (37·2%) | 2690 (34·0%) | 3539 (39·4%) | 1289 (41·4%) | 4951 (36·7%) | |
| Male | 41 025 (56·0%) | 21 758 (59·8%) | 7001 (58·9%) | 11 097 (62·5%) | 5199 (65·8%) | 5415 (60·3%) | 1822 (58·5%) | 8504 (63·1%) | |
| Data missing | 195 (0·3%) | 88 (0·2%) | 22 (0·2%) | 43 (0·2%) | 12 (0·2%) | 19 (0·2%) | 4 (0·1%) | 31 (0·2%) | |
| Deprivation, IMD quintile† | |||||||||
| 1 | 10 408 (14·2%) | 5201 (14·3%) | 1773 (14·9%) | 2437 (13·7%) | 1152 (14·6%) | 1384 (15·4%) | 466 (15·0%) | 1885 (14·0%) | |
| 2 | 12 853 (17·6%) | 6439 (17·7%) | 2147 (18·0%) | 2996 (16·9%) | 1431 (18·1%) | 1634 (18·2%) | 552 (17·7%) | 2305 (17·1%) | |
| 3 | 15 822 (21·6%) | 7855 (21·6%) | 2595 (21·8%) | 3793 (21·4%) | 1631 (20·6%) | 1986 (22·1%) | 633 (20·3%) | 3035 (22·5%) | |
| 4 | 16 104 (22·0%) | 8069 (22·2%) | 2621 (22·0%) | 4101 (23·1%) | 1748 (22·1%) | 2012 (22·4%) | 718 (23·0%) | 3083 (22·9%) | |
| 5 | 17 997 (24·6%) | 8801 (24·2%) | 2759 (23·2%) | 4424 (24·9%) | 1939 (24·5%) | 1956 (21·8%) | 745 (23·9%) | 3177 (23·6%) | |
| Data missing | 13 (<0·1%) | 2 (<0·1%) | 0 | 1 (<0·1%) | 0 | 1 (<0·1%) | 1 (<0·1%) | 1 (<0·1%) | |
| Race or ethnicity | |||||||||
| White | 53 780 (73·5%) | 26 431 (72·7%) | 8678 (73·0%) | 12 896 (72·6%) | 5438 (68·8%) | 6624 (73·8%) | 2282 (73·3%) | 9173 (68·0%) | |
| South Asian | 3318 (4·5%) | 1630 (4·5%) | 593 (5·0%) | 799 (4·5%) | 441 (5·6%) | 369 (4·1%) | 102 (3·3%) | 777 (5·8%) | |
| East Asian | 484 (0·7%) | 249 (0·7%) | 96 (0·8%) | 113 (0·6%) | 82 (1·0%) | 55 (0·6%) | 15 (0·5%) | 142 (1·1%) | |
| Black | 2480 (3·4%) | 1433 (3·9%) | 508 (4·3%) | 822 (4·6%) | 346 (4·4%) | 306 (3·4%) | 114 (3·7%) | 627 (4·6%) | |
| Other ethnic minority‡ | 4646 (6·3%) | 2435 (6·7%) | 751 (6·3%) | 1145 (6·4%) | 641 (8·1%) | 491 (5·5%) | 203 (6·5%) | 1171 (8·7%) | |
| Data missing | 8489 (11·6%) | 4189 (11·5%) | 1269 (10·7%) | 1977 (11·1%) | 953 (12·1%) | 1128 (12·6%) | 399 (12·8%) | 1596 (11·8%) | |
| Diabetes | |||||||||
| No | 49 765 (75·8%) | 24 481 (73·6%) | 7878 (71·9%) | 11 265 (69·7%) | 5694 (77·9%) | 5948 (72·4%) | 2173 (77·7%) | 9194 (74·3%) | |
| Yes | 15 855 (24·2%) | 8792 (26·4%) | 3081 (28·1%) | 4891 (30·3%) | 1615 (22·1%) | 2266 (27·6%) | 625 (22·3%) | 3173 (25·7%) | |
| Obesity | |||||||||
| No | 53 415 (73·0%) | 26 397 (72·6%) | 8476 (71·3%) | 12 656 (71·3%) | 5784 (73·2%) | 6331 (70·6%) | 2304 (74·0%) | 9498 (70·4%) | |
| Yes | 7329 (10·0%) | 4230 (11·6%) | 1583 (13·3%) | 2208 (12·4%) | 985 (12·5%) | 1226 (13·7%) | 296 (9·5%) | 2059 (15·3%) | |
| Data missing | 12 453 (17·0%) | 5740 (15·8%) | 1836 (15·4%) | 2888 (16·3%) | 1132 (14·3%) | 1416 (15·8%) | 515 (16·5%) | 1929 (14·3%) | |
| Chronic cardiac disease | |||||||||
| No | 45 563 (62·2%) | 21 808 (60·0%) | 7117 (59·8%) | 10 400 (58·6%) | 5332 (67·5%) | 4077 (45·4%) | 1923 (61·7%) | 8787 (65·2%) | |
| Yes | 22 563 (30·8%) | 12 758 (35·1%) | 4235 (35·6%) | 6436 (36·3%) | 2201 (27·9%) | 4496 (50·1%) | 995 (31·9%) | 4025 (29·8%) | |
| Data missing | 5071 (6·9%) | 1801 (5·0%) | 543 (4·6%) | 916 (5·2%) | 368 (4·7%) | 400 (4·5%) | 197 (6·3%) | 674 (5·0%) | |
| Chronic pulmonary disease | |||||||||
| No | 55 604 (76·0%) | 27 916 (76·8%) | 9261 (77·9%) | 13 619 (76·7%) | 6404 (81·1%) | 6665 (74·3%) | 2461 (79·0%) | 10 468 (77·6%) | |
| Yes | 12 235 (16·7%) | 6472 (17·8%) | 2002 (16·8%) | 3143 (17·7%) | 1100 (13·9%) | 1791 (20·0%) | 444 (14·3%) | 2289 (17·0%) | |
| Data missing | 5358 (7·3%) | 1979 (5·4%) | 632 (5·3%) | 990 (5·6%) | 397 (5·0%) | 517 (5·8%) | 210 (6·7%) | 729 (5·4%) | |
| Asthma | |||||||||
| No | 58 352 (79·7%) | 29 806 (82·0%) | 9782 (82·2%) | 14 657 (82·6%) | 6525 (82·6%) | 7286 (81·2%) | 2572 (82·6%) | 10 852 (80·5%) | |
| Yes | 9298 (12·7%) | 4447 (12·2%) | 1482 (12·5%) | 2039 (11·5%) | 977 (12·4%) | 1141 (12·7%) | 320 (10·3%) | 1849 (13·7%) | |
| Data missing | 5547 (7·6%) | 2114 (5·8%) | 631 (5·3%) | 1056 (5·9%) | 399 (5·0%) | 546 (6·1%) | 223 (7·2%) | 785 (5·8%) | |
| Chronic kidney disease | |||||||||
| No | 55 458 (75·8%) | 26 793 (73·7%) | 8582 (72·1%) | 11 962 (67·4%) | 6284 (79·5%) | 6434 (71·7%) | 2368 (76·0%) | 10 654 (79·0%) | |
| Yes | 12 182 (16·6%) | 7503 (20·6%) | 2661 (22·4%) | 4785 (27·0%) | 1166 (14·8%) | 2008 (22·4%) | 525 (16·9%) | 2070 (15·3%) | |
| Data missing | 5557 (7·6%) | 2071 (5·7%) | 652 (5·5%) | 1005 (5·7%) | 451 (5·7%) | 531 (5·9%) | 222 (7·1%) | 762 (5·7%) | |
| Moderate or severe liver disease | |||||||||
| No | 65 646 (89·7%) | 33 005 (90·8%) | 10 769 (90·5%) | 16 111 (90·8%) | 6879 (87·1%) | 8162 (91·0%) | 2764 (88·7%) | 12 314 (91·3%) | |
| Yes | 1340 (1·8%) | 916 (2·5%) | 358 (3·0%) | 413 (2·3%) | 528 (6·7%) | 179 (2·0%) | 96 (3·1%) | 281 (2·1%) | |
| Data missing | 6211 (8·5%) | 2446 (6·7%) | 768 (6·5%) | 1228 (6·9%) | 494 (6·3%) | 632 (7·0%) | 255 (8·2%) | 891 (6·6%) | |
| Mild liver disease | |||||||||
| No | 65 784 (89·9%) | 33 164 (91·2%) | 10 837 (91·1%) | 16 169 (91·1%) | 7096 (89·8%) | 8178 (91·1%) | 2792 (89·6%) | 12 338 (91·5%) | |
| Yes | 1035 (1·4%) | 635 (1·7%) | 240 (2·0%) | 294 (1·7%) | 269 (3·4%) | 132 (1·5%) | 60 (1·9%) | 222 (1·6%) | |
| Data missing | 6378 (8·7%) | 2568 (7·1%) | 818 (6·9%) | 1289 (7·3%) | 536 (6·8%) | 663 (7·4%) | 263 (8·4%) | 926 (6·9%) | |
| Chronic neurological disorder | |||||||||
| No | 58 511 (79·9%) | 29 546 (81·2%) | 9725 (81·8%) | 14 440 (81·3%) | 6700 (84·8%) | 7357 (82·0%) | 2048 (65·7%) | 11 352 (84·2%) | |
| Yes | 8802 (12·0%) | 4559 (12·5%) | 1467 (12·3%) | 2167 (12·2%) | 729 (9·2%) | 1024 (11·4%) | 845 (27·1%) | 1309 (9·7%) | |
| Data missing | 5884 (8·0%) | 2262 (6·2%) | 703 (5·9%) | 1145 (6·4%) | 472 (6·0%) | 592 (6·6%) | 222 (7·1%) | 825 (6·1%) | |
| Malignant neoplasm | |||||||||
| No | 60 050 (82·0%) | 29 952 (82·4%) | 9485 (79·7%) | 14 643 (82·5%) | 6620 (83·8%) | 7378 (82·2%) | 2564 (82·3%) | 11 283 (83·7%) | |
| Yes | 7072 (9·7%) | 4075 (11·2%) | 1675 (14·1%) | 1932 (10·9%) | 819 (10·4%) | 994 (11·1%) | 307 (9·9%) | 1341 (9·9%) | |
| Data missing | 6075 (8·3%) | 2340 (6·4%) | 735 (6·2%) | 1177 (6·6%) | 462 (5·8%) | 601 (6·7%) | 244 (7·8%) | 862 (6·4%) | |
| Chronic haematological disease | |||||||||
| No | 64 082 (87·5%) | 32 079 (88·2%) | 10 150 (85·3%) | 15 622 (88·0%) | 6958 (88·1%) | 7906 (88·1%) | 2737 (87·9%) | 12 003 (89·0%) | |
| Yes | 2982 (4·1%) | 1907 (5·2%) | 1017 (8·5%) | 942 (5·3%) | 447 (5·7%) | 461 (5·15) | 122 (3·9%) | 600 (4·4%) | |
| Data missing | 6133 (8·4%) | 2381 (6·5%) | 728 (6·1%) | 1188 (6·7%) | 496 (6·3%) | 606 (6·8%) | 256 (8·2%) | 883 (6·5%) | |
| HIV/AIDs | |||||||||
| No | 65 920 (90·1%) | 33 268 (91·5%) | 10 828 (91·0%) | 16 190 (91·2%) | 7256 (91·8%) | 8195 (91·3%) | 2809 (90·2%) | 12 360 (91·7%) | |
| Yes | 256 (0·3%) | 149 (0·4%) | 57 (0·5%) | 82 (0·5%) | 42 (0·5%) | 28 (0·3%) | 13 (0·4%) | 57 (0·4%) | |
| Data missing | 7021 (9·6%) | 2950 (8·1%) | 1010 (8·5%) | 1480 (8·3%) | 603 (7·6%) | 750 (8·4%) | 293 (9·4%) | 1069 (7·9%) | |
| Rheumatological disorder | |||||||||
| No | 59 168 (80·8%) | 29 823 (82·0%) | 9663 (81·2%) | 14 540 (81·9%) | 6708 (84·9%) | 7294 (81·3%) | 2512 (80·6%) | 11 245 (83·4%) | |
| Yes | 7724 (10·6%) | 4075 (11·2%) | 1462 (12·3%) | 1961 (11·0%) | 701 (8·9%) | 1061 (11·8%) | 353 (11·3%) | 1358 (10·1%) | |
| Data missing | 6305 (8·6%) | 2469 (6·8%) | 770 (6·5%) | 1251 (7·0%) | 492 (6·2%) | 618 (6·9%) | 250 (8·0%) | 883 (6·5%) | |
| Dementia | |||||||||
| No | 55 758 (76·2%) | 28 473 (78·3%) | 9548 (80·3%) | 13 583 (76·5%) | 6708 (84·9%) | 7079 (78·9%) | 2237 (71·8%) | 11 449 (84·9%) | |
| Yes | 11 682 (16·0%) | 5668 (15·6%) | 1624 (13·7%) | 3064 (17·3%) | 750 (9·5%) | 1306 (14·6%) | 645 (20·7%) | 1239 (9·2%) | |
| Data missing | 5757 (7·9%) | 2226 (6·1%) | 723 (6·1%) | 1105 (6·2%) | 443 (5·6%) | 588 (6·6%) | 233 (7·5%) | 798 (5·9%) | |
| Smoking | |||||||||
| Never smoked | 23 944 (32·7%) | 11 976 (32·9%) | 4071 (34·2%) | 5577 (31·4%) | 2811 (35·6%) | 2872 (32·0%) | 889 (28·5%) | 4894 (36·3%) | |
| Current smoker | 3895 (5·3%) | 1927 (5·3%) | 677 (5·7%) | 875 (4·9%) | 508 (6·4%) | 459 (5·1%) | 188 (6·0%) | 694 (5·1%) | |
| Former smoker | 15 834 (21·6%) | 8533 (23·5%) | 2914 (24·5%) | 4179 (23·5%) | 1740 (22·0%) | 2317 (25·8%) | 630 (20·2%) | 3304 (24·5%) | |
| Data missing | 29 524 (40·3%) | 13 931 (38·3%) | 4233 (35·6%) | 7121 (40·1%) | 2842 (36·0%) | 3325 (37·1%) | 1408 (45·2%) | 4594 (34·1%) | |
Data are n or n (%). No means patients didn't have the comorbidity or characteristic, yes means they did. IMD=Index of Multiple Deprivation.
*
Severe acute respiratory infection was contained within case definition so was not counted as a complication.
†
1=least deprived, 5=most deprived.
‡
Includes West Asian, Latinx, Aboriginal, and First Nations People.